Johnson & Johnson vaccine: EU regulator says blood clot 'very rare side effect'
Published
The EU's drugs regulator says the benefits of the Covid-19 vaccine still outweigh the risks.
Full ArticlePublished
The EU's drugs regulator says the benefits of the Covid-19 vaccine still outweigh the risks.
Full ArticleA political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's..
The EU's drug regulator has been reviewing AstraZeneca's coronavirus vaccine over concerns about a very rare, but potentially fatal..